Stockholm May 4, 2020:
First result from the research study with one thousand randomely citizens of Stockholm, in Sweden, doing home sampling using Capitainer for Covid-19 immunity
The Capitainer qDBS solution is designed to enable convenient and quantitative blood sampling at the fingertip.
KTH, the Royal Institute of Technology, are doing a research study for home sampling using Capitainer as the device. The study is based on home sampling to be sent in for analyze at a laboratory for verification of Covid-19 immunity. 1 000 sampling kits were sent out beginning of April and another 1 000 sent out end of April.
Based on over 550 responses, 10% of the Stockholm residents are infected with Covid-19, based on home sampling with Capitainer qDBS.
Some of the published news, TV-spots as of 2020-05-04, see below link.
National public service and news:
Starts approx. after 7:35 minutes.